Barts Health NHS Trust is an NHS trust based in London, England. Established in 2012, it runs five hospitals throughout the City of London and East London, and is one of the largest NHS trusts in England.

During the past decade, Royal London Hospital conducted 121 clinical trials. In the 10-year time frame, 121 clinical trials started and 36 clinical trials were completed, i.e. on average, 29.8% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 23 clinical trials were completed. i.e. 51.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal London Hospital" #1 sponsor was "Children's Cancer and Leukaemia Group" with 15 trials, followed by "Queen Mary University of London" with 12 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored, "Barts & The London NHS Trust" with 7 trials sponsored and "Celgene" with 7 trials sponsored. Other sponsors include 128 different institutions and companies that sponsored additional 108 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal London Hospital" #1 collaborator was "Barts & The London NHS Trust" with 7 trials as a collaborator, "NHS Lothian" with 4 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 4 trials as a collaborator, "Queen Mary University of London" with 3 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 128 different institutions and companies that were collaborators in the rest 133 trials.

According to Clinical.Site data, the most researched conditions in "Royal London Hospital" are "Sickle Cell Disease" (8 trials), "Brain and Central Nervous System Tumors" (7 trials), "Crohn Disease" (7 trials), "Hemophilia A" (4 trials) and "Neuroblastoma" (4 trials). Many other conditions were trialed in "Royal London Hospital" in a lesser frequency.

Most popular intervention types in "Royal London Hospital" are "Drug" (109 trials), "Other" (24 trials), "Procedure" (23 trials), "Device" (17 trials) and "Biological" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "adjuvant therapy" (9 trials), "cisplatin" (8 trials), "conventional surgery" (7 trials) and "radiation therapy" (7 trials). Other intervention names were less common.

The vast majority of trials in "Royal London Hospital" are 173 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Royal London Hospital". undefined are not yet recruiting, 34 are recruiting, 17 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 89 completed trials in Royal London Hospital, 1 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Royal London Hospital, 8 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 29 trials that are defined as “Not Applicable".